Marloes L C Hagemans

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. pmc PAS-positive lymphocyte vacuoles can be used as diagnostic screening test for Pompe disease
    Marloes L C Hagemans
    Department of Paediatrics, Division of Metabolic Diseases and Genetics, Erasmus MC University Medical Center Sophia Children s Hospital, Rotterdam, The Netherlands
    J Inherit Metab Dis 33:133-9. 2010
  2. ncbi request reprint Impact of late-onset Pompe disease on participation in daily life activities: evaluation of the Rotterdam Handicap Scale
    M L C Hagemans
    Department of Pediatrics, Division of Metabolic Diseases and Genetics, Erasmus MC Sophia, Dr Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands
    Neuromuscul Disord 17:537-43. 2007
  3. pmc The quick motor function test: a new tool to rate clinical severity and motor function in Pompe patients
    Carine I van Capelle
    Department of Pediatrics, Division of Metabolic Diseases and Genetics, Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center, Postbus 2060, 3000 CB, Rotterdam, The Netherlands
    J Inherit Metab Dis 35:317-23. 2012
  4. doi request reprint Enzyme replacement therapy and fatigue in adults with Pompe disease
    Deniz Güngör
    Center for Lysosomal and Metabolic Diseases, Department of Pediatrics, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    Mol Genet Metab 109:174-8. 2013
  5. pmc Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study
    Nadine A M E van der Beek
    Department of Neurology, Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center, s Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands
    Orphanet J Rare Dis 7:88. 2012
  6. pmc Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy
    Deniz Güngör
    Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center, Dr, Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands
    Orphanet J Rare Dis 6:34. 2011
  7. pmc Fatigue: an important feature of late-onset Pompe disease
    Marloes L C Hagemans
    Department of Paediatrics, Division of Metabolic Diseases and Genetics, Erasmus MC Sophia, Dr Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands
    J Neurol 254:941-5. 2007
  8. pmc Burden of illness of Pompe disease in patients only receiving supportive care
    Tim A Kanters
    Department of Health Policy and Management, Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands
    J Inherit Metab Dis 34:1045-52. 2011
  9. ncbi request reprint The natural course of non-classic Pompe's disease; a review of 225 published cases
    Leon P F Winkel
    Department of Paediatrics, Division of Metabolic Diseases and Genetics, Erasmus MC Sophia, Dr Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands
    J Neurol 252:875-84. 2005
  10. pmc Mucopolysaccharidosis: cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI
    Marion M M G Brands
    Department of Pediatrics, Division of Metabolic Diseases and Genetics, Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center Sophia s Children s Hospital, Dr Molewaterplein 60, Rotterdam, The Netherlands
    J Inherit Metab Dis 36:227-34. 2013

Collaborators

Detail Information

Publications16

  1. pmc PAS-positive lymphocyte vacuoles can be used as diagnostic screening test for Pompe disease
    Marloes L C Hagemans
    Department of Paediatrics, Division of Metabolic Diseases and Genetics, Erasmus MC University Medical Center Sophia Children s Hospital, Rotterdam, The Netherlands
    J Inherit Metab Dis 33:133-9. 2010
    ..The percentage of PAS-positive lymphocytes is convenient for use in clinical practice but should always be interpreted in combination with other clinical and laboratory parameters...
  2. ncbi request reprint Impact of late-onset Pompe disease on participation in daily life activities: evaluation of the Rotterdam Handicap Scale
    M L C Hagemans
    Department of Pediatrics, Division of Metabolic Diseases and Genetics, Erasmus MC Sophia, Dr Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands
    Neuromuscul Disord 17:537-43. 2007
    ..We conclude that the RHS seems suitable for this patient population and that Pompe disease has a large impact on the participation in daily life activities, in particular on the ability of patients to fulfil their work or study...
  3. pmc The quick motor function test: a new tool to rate clinical severity and motor function in Pompe patients
    Carine I van Capelle
    Department of Pediatrics, Division of Metabolic Diseases and Genetics, Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center, Postbus 2060, 3000 CB, Rotterdam, The Netherlands
    J Inherit Metab Dis 35:317-23. 2012
    ..In conclusion, the Quick Motor Function Test can reliably rate clinical severity and motor function in children and adults with Pompe disease...
  4. doi request reprint Enzyme replacement therapy and fatigue in adults with Pompe disease
    Deniz Güngör
    Center for Lysosomal and Metabolic Diseases, Department of Pediatrics, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    Mol Genet Metab 109:174-8. 2013
    ..Pompe disease is a hereditary metabolic myopathy, for which enzyme replacement therapy (ERT) has been available since 2006. We investigated whether ERT reduces fatigue in adult patients with Pompe disease...
  5. pmc Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study
    Nadine A M E van der Beek
    Department of Neurology, Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center, s Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands
    Orphanet J Rare Dis 7:88. 2012
    ..Furthermore, we defined the natural disease course and identified prognostic factors for disease progression...
  6. pmc Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy
    Deniz Güngör
    Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center, Dr, Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands
    Orphanet J Rare Dis 6:34. 2011
    ..Our objective was to determine the survival of adults with Pompe disease not receiving ERT and to identify prognostic factors associated with survival...
  7. pmc Fatigue: an important feature of late-onset Pompe disease
    Marloes L C Hagemans
    Department of Paediatrics, Division of Metabolic Diseases and Genetics, Erasmus MC Sophia, Dr Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands
    J Neurol 254:941-5. 2007
    ..To investigate the prevalence and severity of fatigue in adult patients with Pompe disease...
  8. pmc Burden of illness of Pompe disease in patients only receiving supportive care
    Tim A Kanters
    Department of Health Policy and Management, Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands
    J Inherit Metab Dis 34:1045-52. 2011
    ....
  9. ncbi request reprint The natural course of non-classic Pompe's disease; a review of 225 published cases
    Leon P F Winkel
    Department of Paediatrics, Division of Metabolic Diseases and Genetics, Erasmus MC Sophia, Dr Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands
    J Neurol 252:875-84. 2005
    ..Studies of non-classic Pompe's disease should focus on these aspects, before enzyme replacement therapy becomes generally available...
  10. pmc Mucopolysaccharidosis: cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI
    Marion M M G Brands
    Department of Pediatrics, Division of Metabolic Diseases and Genetics, Center for Lysosomal and Metabolic Diseases, Erasmus MC University Medical Center Sophia s Children s Hospital, Dr Molewaterplein 60, Rotterdam, The Netherlands
    J Inherit Metab Dis 36:227-34. 2013
    ..The most severe cardiac disease was observed in a subgroup of young MPS VI patients. While ERT had an effect on LVMI and IVSd, it apparently had little or none on valve regurgitation...
  11. ncbi request reprint Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy
    N A M E Van der Beek
    Department of Neurology, Erasmus MC, Rotterdam, The Netherlands
    Acta Neurol Belg 106:82-6. 2006
    ..Detailed knowledge about the natural course of the disease becomes more and more essential to determine the indication and timing of treatment...
  12. doi request reprint Eight years experience with enzyme replacement therapy in two children and one adult with Pompe disease
    C I van Capelle
    Department of Pediatrics, Division of Metabolic Diseases and Genetics, Erasmus MC University Medical Center Sophia Children s Hospital, P O Box 2060, 3000 CB Rotterdam, The Netherlands
    Neuromuscul Disord 18:447-52. 2008
    ..He showed further improvement of strength and reached normal values for age during the extension phase. The results indicate that both long-term follow-up and timing of treatment are important topics for future studies...
  13. ncbi request reprint Course of disability and respiratory function in untreated late-onset Pompe disease
    M L C Hagemans
    Department of Metabolic Diseases and Genetics, Erasmus MC Sophia, Rotterdam, The Netherlands
    Neurology 66:581-3. 2006
    ..This study illustrates the progressiveness of late-onset Pompe disease and indicates the need for close clinical follow-up of both children and adults with this disorder...
  14. ncbi request reprint Disease severity in children and adults with Pompe disease related to age and disease duration
    M L C Hagemans
    Division of Metabolic Diseases and Genetics, Department of Pediatrics, Erasmus MC Sophia, Rotterdam, The Netherlands
    Neurology 64:2139-41. 2005
    ..The patient group under age 15 included a subgroup with a more severe and rapid course of the disease. They require more intensive follow-up and early intervention, before irreversible damage has occurred...
  15. ncbi request reprint Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients
    M L C Hagemans
    Department of Metabolic Diseases and Genetics, Erasmus MC Sophia, Rotterdam, The Netherlands
    Brain 128:671-7. 2005
    ..The follow-up of patients with late-onset Pompe's disease should focus on respiratory and limb-girdle muscle function, the capacity to perform daily activities, and the presentation of fatigue and pain...
  16. ncbi request reprint Late-onset Pompe disease primarily affects quality of life in physical health domains
    M L C Hagemans
    Department of Pediatrics, Division of Metabolic Diseases and Genetics, Erasmus MC Sophia, Rotterdam, The Netherlands
    Neurology 63:1688-92. 2004
    ..To investigate quality of life in an international population of patients with late-onset Pompe disease...